Results 201 to 210 of about 8,840 (216)

NMOSD: How Long to Treat

Multiple Sclerosis and Related Disorders, 2022
openaire   +1 more source

A comparative study on clinico-radiological profile, treatment responses and outcomes of double seronegative NMOSD compared to AQP4-IgG positive NMOSD, and MOGAD

Multiple Sclerosis and Related Disorders
Sruthi S Nair, Soumya Sundaram, Bejoy Thomas   +2 more
exaly  

A Study of HBM9161 in NMOSD Patients

Case Medical Research, 2020
openaire   +1 more source

Concurrent aquaporin-4-positive NMOSD and neurosyphilis: A case report

Multiple Sclerosis and Related Disorders, 2019
exaly  

Is There a Prodrome to NMOSD? An Investigation of Neurologic Symptoms Preceding the First NMOSD Attack (P11-14.005)

Neurology
Sydney Lee, Ruth-Ann Marrie, Giulia Fadda, Liesly Lee, Alexandra Muccilli, Manav Vyas, Andrea Konig, Dalia Rotstein   +7 more
openaire   +1 more source

Epidemiology of NMOSD in Central Serbia

2018
Irena P. Dujmovic Basuroski, Jelena Drulovic   +1 more
openaire   +1 more source

Eculizumab bei NMOSD zugelassen

NeuroTransmitter, 2019
openaire   +1 more source

MS and NMOSD in African-Americans

Case Medical Research, 2019
openaire   +1 more source

ACT with NMOSD: A targeted, telehealth-delivered mental health intervention for patients & caregivers

Multiple Sclerosis and Related Disorders
C Virginia O'Hayer, Thomas Leist, Wendy Erler   +2 more
exaly  

Is there truly no progression in NMOSD and MOGAD?

Multiple Sclerosis and Related Disorders
J, Lechner-Scott, G, Giovannoni, Hawkes, Ch, M, Levy, Yeh, Ea   +4 more
openaire   +2 more sources